Calumet, Inc. (NASDAQ:CLMT - Get Free Report) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $14.83 and traded as high as $16.82. Calumet shares last traded at $16.34, with a volume of 1,282,363 shares traded.
Analyst Ratings Changes
A number of analysts have recently commented on CLMT shares. The Goldman Sachs Group lowered their price target on Calumet from $16.00 to $14.00 and set a "buy" rating for the company in a research note on Wednesday, April 30th. Wells Fargo & Company lowered their target price on shares of Calumet from $23.00 to $21.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Bank of America initiated coverage on shares of Calumet in a report on Tuesday, May 13th. They issued a "buy" rating and a $15.00 target price on the stock. Finally, UBS Group raised shares of Calumet from a "sell" rating to a "neutral" rating and decreased their price target for the company from $15.00 to $12.00 in a report on Monday, March 17th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $18.50.
Read Our Latest Analysis on Calumet
Calumet Trading Up 2.2%
The firm has a market capitalization of $1.44 billion, a P/E ratio of -4.18 and a beta of 0.93. The business has a 50 day moving average of $13.77 and a 200-day moving average of $14.83.
Calumet (NASDAQ:CLMT - Get Free Report) last issued its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The firm had revenue of $993.90 million for the quarter, compared to the consensus estimate of $899.62 million. During the same period last year, the company earned ($0.51) earnings per share. The firm's quarterly revenue was down 1.2% compared to the same quarter last year. On average, analysts anticipate that Calumet, Inc. will post -3.02 EPS for the current fiscal year.
Insider Buying and Selling
In other Calumet news, SVP Gregory J. Morical sold 25,123 shares of Calumet stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $16.69, for a total value of $419,302.87. Following the sale, the senior vice president owned 39,415 shares of the company's stock, valued at $657,836.35. This trade represents a 38.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jennifer Straumins sold 100,000 shares of the company's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $13.17, for a total value of $1,317,000.00. Following the transaction, the director directly owned 1,084,589 shares of the company's stock, valued at $14,284,037.13. This represents a 8.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 278,778 shares of company stock valued at $4,147,258. Company insiders own 4.07% of the company's stock.
Hedge Funds Weigh In On Calumet
An institutional investor recently raised its position in Calumet stock. Goldman Sachs Group Inc. lifted its holdings in Calumet, Inc. (NASDAQ:CLMT - Free Report) by 33.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 465,269 shares of the oil and gas company's stock after purchasing an additional 116,777 shares during the quarter. Goldman Sachs Group Inc. owned 0.54% of Calumet worth $5,900,000 as of its most recent SEC filing. Institutional investors own 34.41% of the company's stock.
Calumet Company Profile
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Stories
Before you consider Calumet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.
While Calumet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.